Share
Many patients receive immunotherapy without a serious complication. Nevertheless, some side effects can worsen quickly, and early recognition matters. The safest approach is to report a significant new symptom rather than decide at home whether it is normal.
This article concerns immune checkpoint inhibitors, including medicines targeting PD-1, PD-L1 and CTLA-4. CAR-T and other immunotherapies have different safety pathways. Follow the advice for the actual treatment you receive.
Why can immunotherapy affect healthy organs?
Checkpoint medicines reduce restraints on immune activity. That may help attack cancer but can also cause inflammation in healthy tissue, called an immune-related adverse event. The skin, bowel, lungs, liver, kidneys and hormone-producing glands can be affected; heart, muscle and neurological problems are less common but potentially serious.
This differs from the familiar picture of chemotherapy causing hair loss or low blood counts. A person may keep their hair and feel relatively well between infusions yet develop an important immune reaction. Combination treatment can also cause side effects from the accompanying medicine.
Know your baseline and contact plan
Before treatment, tell the team your usual bowel frequency, breathing symptoms, skin problems, energy levels and existing headaches or weakness. Discuss autoimmune conditions, thyroid disease, diabetes, transplantation and previous immune reactions. Keep a current medicine list.
You do not need to monitor every sensation anxiously. Recognising a meaningful change is the aim. “Four loose stools today when I normally have one formed stool” is more useful than “my stomach is not right”.
Have daytime and out-of-hours arrangements written down. Know where to attend if the team cannot be reached promptly. A booking number is not necessarily an emergency service.
Which changes need attention?
This table is an action guide, not a way to diagnose the affected organ at home. Infection, another medicine or the cancer itself may cause similar symptoms.
If the table extends beyond your screen, swipe or scroll sideways to read every column.
Symptom | Possible concern | What to do |
|---|---|---|
New cough or breathlessness | Lung inflammation, infection, clot or another chest problem | Contact the team promptly; severe or rapidly worsening breathlessness is an emergency. |
New diarrhoea, abdominal pain or blood in stool | Bowel inflammation or infection | Report the change the same day; severe pain, bleeding or dehydration needs urgent assessment. |
Yellow eyes or skin, dark urine, persistent nausea | Liver inflammation or another liver/biliary problem | Obtain prompt advice rather than waiting for the next infusion. |
Unusual exhaustion, dizziness, headache, vomiting or marked thirst | Hormone-gland or blood-sugar disturbance, among other causes | Contact the team promptly; collapse, confusion or severe illness requires emergency care. |
Blistering, peeling or widespread rash, mouth or eye sores | Potentially serious skin reaction | Seek urgent assessment. |
Chest pain, palpitations, fainting or new muscle weakness | Possible heart, muscle or nerve inflammation | Seek urgent assessment, particularly when symptoms occur together. |
Much less urine, swelling or blood in urine | Kidney inflammation or another urinary problem | Contact the team promptly. |
New visual changes, difficulty walking or unexplained neurological symptoms also warrant urgent advice. A symptom is not safe to ignore because it is missing from a short leaflet.
Diarrhoea needs more than an over-the-counter remedy
A brief bowel upset and immune-related colitis can initially look similar. Record stools compared with your baseline, blood or mucus, pain, fever and whether you can drink adequately.
Do not repeatedly suppress new or worsening diarrhoea without telling the oncology team. Assessment may include stool and blood tests and sometimes specialist investigation. Infection and immune inflammation need different management, and both can occur.
If you cannot retain fluids, pass little urine, feel faint or have severe pain or bleeding, seek urgent assessment rather than a routine appointment.
Fatigue can be a clue, not merely an inconvenience
Tiredness is common, but a clear change accompanied by dizziness, headache, nausea, unusual thirst or other new symptoms needs review. Checkpoint treatment can disturb thyroid, pituitary, adrenal or pancreatic function. Blood tests sometimes reveal problems before symptoms are obvious.
This is why monitoring matters even when you feel well. Normal tests last month do not rule out a new problem now.
Some hormonal complications require ongoing replacement treatment rather than resolving when immunotherapy stops. Follow the prescribed medicine and any illness or emergency instructions for the specific condition.
Can reactions occur after the last dose?
Yes. Immune-related side effects may start during treatment, after many doses or after treatment has ended. Keep immunotherapy in your long-term medical history.
Tell any clinician the medicine name, treatment dates and previous immune complications. A patient attending an emergency department for breathlessness may not realise that a dose given some time earlier is relevant.
Carry the treatment alert card supplied by your hospital, or keep equivalent details readily accessible. A family member should know where to find them.
What happens when you report a symptom?
The team assesses urgency, timing, severity and possible causes. You may need examination, blood or urine tests, infection testing, imaging or input from another specialist.
Not every new problem is caused by immunotherapy. Assuming all symptoms are immune-related can be as unsafe as overlooking that possibility. A blood clot, infection or dehydration may need a different urgent response.
A useful message states the medicine, last dose, when the problem started and what has changed. For severe symptoms, do not spend time preparing a perfect message before obtaining emergency help.
How are immune-related complications treated?
Mild problems may need observation or symptom treatment. More significant reactions can require holding immunotherapy and treating inflammation, often with corticosteroids. Some situations require other immune-suppressing medicines, hormone replacement or hospital care.
Do not start leftover steroids or alter their dose yourself. The cause needs assessment and the correct treatment varies. Stopping a prescribed steroid suddenly can also be unsafe. Follow the written schedule and ask whenever tapering instructions are unclear.
Some patients worry that controlling inflammation will cancel all anticancer benefit. A dangerous reaction should not be left untreated for that reason. The team balances the cancer plan with management of toxicity, with safety the immediate priority.
Will reporting symptoms stop treatment permanently?
Not necessarily. A temporary hold or adjustment does not automatically mean abandoning an effective medicine. Some patients can restart after recovery; some complications make restarting too risky. The affected organ, severity, recovery and available cancer treatments matter.
Hiding symptoms to protect access to a drug can have the opposite effect by allowing a more serious complication to develop. Early reporting gives the team a better opportunity to intervene.
Ask what must improve before treatment can resume and how benefit and risk will be reconsidered. A planned pause is different from an unexplained interruption.
How can caregivers help?
Relatives may notice confusion, unusual sleepiness, changes in walking or reduced intake before the patient recognises them. Report important changes respectfully, including how the person differs from their usual state.
Follow the monitoring plan rather than creating an exhausting schedule of unrequested measurements. A normal home oxygen reading or temperature should not overrule severe symptoms.
Keep medicines, emergency contacts and treatment details accessible. Clarify which messages can wait for clinic hours and which require an emergency department.
Frequently asked questions
Can normal blood tests exclude all side effects?
No. Some complications need examination or imaging. New breathlessness or neurological symptoms still require assessment despite satisfactory recent routine blood results.
Does a rash mean treatment is working?
Not reliably for an individual patient. A rash needs assessment on its own merits. It should not be endured as proof of a stronger anticancer effect.
Can I use ordinary medicines for a mild symptom?
Follow your treatment team’s symptom plan. Do not conceal a new or worsening problem or add medicines that complicate assessment. Include herbal and over-the-counter products when discussing medicines.
How long should I retain the immunotherapy alert information?
Keep it in your lasting medical record. Previous immunotherapy remains relevant if an unexplained inflammatory problem develops after treatment.
Reporting symptoms is part of treatment, not an interruption to it. You do not have to prove that a symptom is serious before asking for help.
Medical information notice: This information is for general education and does not replace individual medical advice. Cancer treatment depends on the diagnosis, stage, tumour biology, previous treatment, general health and individual circumstances.
